Tri-county voters must go to the polls
By Loredana Carson In November 2014, only 203,783 out of 433,064 registered voters cast a ballot, according to the Ventura County registrar. Voter participation in general throughout California has declined in the past decade, according to the California Civic Engagement Project. The project reports that over the past three elections, registered voter turnout was 54.9 Read More →
Oxnard planning downtown revitalization
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Miramar resort redevelopment expected to be finished in 2018
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
FDA gives big win to Amgen in biosimilars race
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Santa Barbara 100 bicycle ride aims to be world-class event
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dubroff: CLU professor scales the summit of Central Coast economics
A rock climbing expert with an innate curiosity about markets, Matthew Fienup found his calling in his mid-30s when he won admission to a doctoral program at UC Santa Barbara’s Bren School of Environmental Management. Now 41 and a professor in California Lutheran University’s Center for Economic Research & Forecasting, he’ll get a view from Read More →
Amgen paying Arrowhead for traits to develop cardiovascular drugs
Amgen will license two traits from a Pasadena pharmaceutical company to develop cardiovascular drugs under a partnership announced Sept. 29. Under the agreement, Thousand Oaks-based Amgen will pay Arrowhead Pharmaceuticals $35 million up front, $21.5 million in the form of an equity investment by Amgen in Arrowhead common stock, and up to $617 million in Read More →
